Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

NCT00004022 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: autologous tumor cell vaccine
BIOLOGICAL: muromonab-CD3
BIOLOGICAL: therapeutic autologous lymphocytes
PROCEDURE: surgical procedure

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]